A detailed history of Financial Gravity Asset Management, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Financial Gravity Asset Management, Inc. holds 17 shares of BMY stock, worth $986. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17
Previous 40 57.5%
Holding current value
$986
Previous $2.12 Million 66.68%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$40.25 - $52.99 $925 - $1,218
-23 Reduced 57.5%
17 $706,000
Q1 2024

Jun 26, 2024

SELL
$47.98 - $54.4 $623 - $707
-13 Reduced 24.53%
40 $2.12 Million
Q1 2024

May 13, 2024

SELL
$47.98 - $54.4 $14,441 - $16,374
-301 Reduced 80.27%
74 $3.99 Million
Q4 2023

Jun 26, 2024

SELL
$48.48 - $57.85 $1,018 - $1,214
-21 Reduced 28.38%
53 $2.6 Million
Q3 2023

Nov 15, 2023

BUY
$57.89 - $64.73 $17,019 - $19,030
294 Added 362.96%
375 $21,000
Q2 2023

Aug 08, 2023

BUY
$63.71 - $70.74 $764 - $848
12 Added 17.39%
81 $15.8 Million
Q1 2023

May 12, 2023

SELL
$65.71 - $74.53 $197 - $223
-3 Reduced 4.17%
69 $6.88 Million
Q4 2022

Feb 15, 2023

SELL
$68.48 - $81.09 $136,069 - $161,125
-1,987 Reduced 96.5%
72 $18.7 Million
Q3 2022

Nov 03, 2022

SELL
$0.13 - $76.84 $242 - $143,537
-1,868 Reduced 47.57%
2,059 $9.63 Million
Q2 2022

Aug 05, 2022

BUY
$72.62 - $79.98 $110,237 - $121,409
1,518 Added 63.01%
3,927 $9.86 Million
Q1 2022

May 13, 2022

SELL
$61.48 - $73.72 $553 - $663
-9 Reduced 0.37%
2,409 $14.4 Million
Q4 2021

Feb 11, 2022

BUY
$53.63 - $62.52 $121,900 - $142,107
2,273 Added 1567.59%
2,418 $8.88 Million
Q2 2021

Aug 11, 2021

SELL
$61.91 - $67.42 $1,485 - $1,618
-24 Reduced 14.2%
145 $67,000
Q1 2021

May 17, 2021

BUY
$59.34 - $66.74 $474 - $533
8 Added 4.97%
169 $10.6 Million
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $9,296 - $10,534
161 New
161 $9,000
Q2 2020

Aug 13, 2020

SELL
$54.82 - $64.09 $70,662 - $82,612
-1,289 Closed
0 $0
Q1 2020

May 12, 2020

SELL
$46.4 - $67.43 $15,636 - $22,723
-337 Reduced 20.73%
1,289 $71,000
Q4 2019

Feb 28, 2020

BUY
$49.21 - $64.19 $48,028 - $62,649
976 Added 150.15%
1,626 $75,000
Q3 2019

Oct 15, 2019

BUY
$42.77 - $50.71 $13,985 - $16,582
327 Added 101.24%
650 $33,000
Q2 2019

Jul 26, 2019

SELL
$44.62 - $49.34 $9,905 - $10,953
-222 Reduced 40.73%
323 $15,000
Q1 2019

Apr 19, 2019

SELL
$45.12 - $53.8 $23,507 - $28,029
-521 Reduced 48.87%
545 $26,000
Q3 2018

Oct 31, 2018

SELL
$55.19 - $62.25 $7,009 - $7,905
-127 Reduced 10.65%
1,066 $53,000
Q2 2018

Aug 14, 2018

BUY
$50.53 - $62.98 $12,935 - $16,122
256 Added 27.32%
1,193 $71,000
Q1 2018

May 23, 2018

BUY
$59.92 - $68.98 $56,145 - $64,634
937 New
937 $48,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Financial Gravity Asset Management, Inc. Portfolio

Follow Financial Gravity Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.